Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
Authors:
- Edwin G. Peña-MartínezEPEdwin G. Peña-Martínez
- Shreya SharmaSSShreya Sharma
- Joshua G. Medina-FelicianoJMJoshua G. Medina-Feliciano
- Elise RootERElise Root
- Lois G. ParksLPLois G. Parks
- Marissa GranittoMGMarissa Granitto
- Diego A. Pomales-MatosDPDiego A. Pomales-Matos
- Jean L. Messon-BirdJMJean L. Messon-Bird
- Adriana C. Barreiro-RosarioABAdriana C. Barreiro-Rosario
- Leandro Sanabria-AlbertoLSLeandro Sanabria-Alberto
- Alejandro Rivera-MaderaARAlejandro Rivera-Madera
- Jessica M. Rodríguez-RíosJRJessica M. Rodríguez-Ríos
Preprint
Abstract
(Summary): Genome-wide association studies (GWAS) have mapped thousands of congenital heart disease (CHD)-associated variants within non-coding regions of the genome. Non-coding variants can alter regulatory mechanisms, such as transcription factor (TF) binding control of gene expression, potentially contributing human diseases. However, with the increasing number of disease-associated variants, comprehensive functional validation remains a significant challenge. In this work, we developed a novel method called SNP Bind-n-Seq to evaluate >3,000 CHD-risk variants for allelic binding for the cardiac TFs NKX2-5, GATA4, and TBX5 in a high-throughput manner. These binding affinity data sets were coupled with a massively parallel reporter assay (MPRA) to screen CHD-risk variant genotype-dependent regulatory activity. We identified 170 variants that exhibit allelic TF binding and 187 that modulate gene expression. Combining both approaches revealed three high-confidence variants with genotype-dependent TF binding, genotype-dependent transcriptional activity, and eQTL behavior in cardiac cells. Collectively, this study provides the first combined high-throughput biochemical and functional genomic evaluation of thousands of CHD-risk variants. Highlights: Allelic binding affinity measurements of ∼9,600 variants for NKX2-5, GATA4, and TBX5 EvaluaFon of >3,000 CHD-risk variants for genotype-dependent regulatory acFvity InteracFon networks idenFfy funcFonal variants and genes involving cardiac eQTLs GraphicalKeywords
All Related Versions
Funding Information
- NIH (SC1GM127231)
- NIH (P20GM103475W)
- NIH (5R25GM061151–20)
- NIH (1T34GM145404)
- NIH (1R25HG012702–01)
- NIH (R01NS099068)
- NSF (1736026)
- NSF (HRD-2008186)
- NSF (1852259)
- NSF (STC-1231306)
- NSF (2050493)
- NSF (1744619)
- University of Puerto Rico Rio Piedras Institutional Funds
- Puerto Rico Science, Technology, and Research Trust
- NIH (R01AI024717)
- NIH (R01AI148276)
- NIH (U24 HG013078)
- NIH (U01 HG011172)
- NIH (P30AR070549)
- NIH (R01HG012872)
This publication has 164 references indexed in Scilit:
- KLF1 Promotes Cardiomyocyte Proliferation and Heart Regeneration Through Regulation of Wnt/β‐Catenin Signaling PathwayAdvanced Science, 2025
- Assessing candidate DLX‐regulated genes in the first pharyngeal arch of chick embryosDevelopmental Dynamics, 2025
- A genome‐wide association study of obstructive heart defects among participants in the National Birth Defects Prevention StudyAmerican Journal of Medical Genetics Part A, 2022
- Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF‐κB signalingJournal of Cellular Biochemistry, 2018
- Clinical, biochemical, and genetic features associated with VARS2 -related mitochondrial diseaseHuman Mutation, 2018
- How many roads lead to cohesinopathies?Developmental Dynamics, 2017
- Functional role of KLF10 in multiple disease processesBioFactors, 2010
- Computational Biology of Transcription Factor Binding2010
- Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart developmentDevelopmental Dynamics, 2008
- Chamber-Specific Cardiac Expression of Tbx5 and Heart Defects in Holt–Oram SyndromeDevelopmental Biology, 1999